Reports

297 Results (Page 2 of 12)

Saudi Arabia Markets Research Reports

Pharmaceuticals

Saudi Arabia Anticoagulants Market Analysis

Saudi Arabia Anticoagulants Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Anticoagulants, commonly known as blood thinners, reduce the risk of blood clots and related consequences by suppressing the clotting mechanisms in the blood. Increased cardiovascular illnesses, an ageing population, greater awareness, technical improvements, advantageous reimbursement policies, and an increase in surgical operations are driving the anticoagulants market. However, there are hazards of bleeding, regulatory requirements, and generic alternatives. The presence of many prominent companies who play a crucial part in developing the industry characterises the global anticoagulants market. Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, Sanofi S.A., Novartis AG, Merck & Co., Inc., and Portola Pharmaceuticals, Inc. are among the prominent participants.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Antiepileptics Drugs Market Analysis

Saudi Arabia Antiepileptics Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Epilepsy is a chronic neurological disorder characterized by recurrent seizures. The market for antiepileptic drugs is driven by the growing prevalence of epilepsy worldwide and the continuous need for effective and well-tolerated medications. Continuous advances in drug research and development help to bring new and improved antiepileptic treatments to market. These developments result in the creation of pharmaceuticals with improved efficacy, safety profiles, and fewer side effects, which drives market expansion. Some prominent players in the market include UCB Pharma, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Johnson & Johnson, Sanofi S.A., Eisai Co., Ltd., Sunovion Pharmaceuticals Inc., Cephalon, Inc., and Teva Pharmaceutical Industries Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Antithrombotic Drugs Market Analysis

Saudi Arabia Antithrombotic Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of cardiovascular disorders, growing geriatric population, developments in medication research, supportive government initiatives and advantageous reimbursement regulations for antithrombotic drugs drive market expansion. The antithrombotic drugs market is dominated by several key players who play a crucial role in driving advancements in the field of cardiovascular medicine. These key players include renowned pharmaceutical companies such as Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Portola Pharmaceuticals, Inc., AstraZeneca PLC, and Bayer AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Asthma Drugs Market Analysis

Saudi Arabia Asthma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for asthma drugs is primarily driven by the increasing prevalence of asthma globally, Growing awareness among patients and healthcare providers about the importance of asthma management and the availability of effective treatment options further fuel market growth. Key players in the asthma drugs market include pharmaceutical companies such as GlaxoSmithKline, Roche, AstraZeneca, Novartis, Merck & Co., and Teva Pharmaceutical Industries.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Atherosclerosis Drugs Market Analysis

Saudi Arabia Atherosclerosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The atherosclerosis drugs market is driven by factors such as the rising prevalence of cardiovascular diseases, advancements in drug development, and growing awareness about early diagnosis and treatment. The key players in the atherosclerosis drugs market include Pfizer Inc., AstraZeneca PLC, Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Amgen Inc., Eli Lilly and Company, Bayer AG, and GlaxoSmithKline PLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Atopic Dermatitis Drugs Market Analysis

Saudi Arabia Atopic Dermatitis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for atopic dermatitis drugs is driven by the increasing prevalence of the condition, especially among children, leading to a demand for effective treatments. Some of the prominent players in the market include Pfizer Inc., Sanofi SA, Novartis AG, Regeneron Pharmaceuticals Inc., Galderma S.A., Leo Pharma A/S, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, and Johnson & Johnson.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Autologous Matrix-induced Chondrogenesis Market Analysis

Saudi Arabia Autologous Matrix-induced Chondrogenesis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The AMIC market is driven by increasing knee injuries and cartilage defects, advancements in regenerative medicine, and the growing geriatric population. However, limited awareness and high costs are restraints. Ongoing research, collaborations, and investments are expected to address restraints and drive further advancements in the AMIC market. Key players globally in AMIC market are Geistlich Pharma AG, Arthrex, Zimmer Biomet Holdings, Smith & Nephew plc, Vericel Corporation, and B. Braun Melsungen AG, among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Axial Spondyloarthritis (axSpA) Market Analysis

Saudi Arabia Axial Spondyloarthritis (axSpA) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. With ongoing research and development efforts, the expansion of treatment options, and increasing patient awareness, the axSpA market is expected to witness significant growth in the coming years. AbbVie Inc., Amgen Inc., Johnson & Johnson, Novartis International AG, Pfizer Inc., Eli Lilly and Company, Merck & Co., UCB S.A., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH are the global key players in axSpA market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Biological Safety Testing Market Analysis

Saudi Arabia Biological safety testing Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The biological safety testing market is driven by increasing demand for biologics, stringent regulatory requirements, rising incidence of infectious diseases, technological advancements, and growth in the biotechnology and pharmaceutical industries. Charles River Laboratories International, Merck KGaA, Lonza Group Ltd., Eurofins Scientific, SGS SA, WuXi AppTec, Toxikon Corporation, Avista Pharma Solutions, Nelson Laboratories, Pace Analytical Services are among the global key players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Biosimilar Monoclonal Antibodies Market Analysis

Saudi Arabia Biosimilar Monoclonal Antibodies Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Market drivers for biosimilar monoclonal antibodies include rising demand for low-cost biologics, the increasing frequency of chronic diseases, and the need for more economical biologic therapeutics. Among the key global pharmaceutical companies in the Biosimilar Monoclonal Antibodies Market are Samsung Bioepis Co., Celltrion Inc., Biocon Ltd., Pfizer Inc., Amgen Inc., Novartis AG (Sandoz), Mylan N.V., Boehringer Ingelheim International GmbH, Fresenius Kabi AG, and Teva Pharmaceutical Industries Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Biosimilars Market Analysis

Saudi Arabia Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Cost-effectiveness, patent expirations of reference biologics, increasing demand for biologic medicines, a supportive regulatory environment, and increased acceptance by healthcare professionals are all main drivers in the biosimilars market. Novartis AG, Pfizer Inc., Amgen Inc., Coherus Biosciences Inc., Mylan NV (Viatris Inc.), and Samsung Bioepis Co., Ltd. are among the top competitors in the studied market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Blood Plasma Market Analysis

Saudi Arabia Blood Plasma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising demand for plasma-derived therapies, advancements in plasma fractionation technologies, rising awareness and adoption of plasma-derived therapies, a favourable regulatory environment, increased investment in plasma collection centres, and a growing need for blood plasma in research and development are key drivers in the blood plasma market. CSL Behring, Grifols, Octapharma, Biotest AG, and Kedrion are some of the major global competitors in the blood plasma industry.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Bone Marrow Aspirate Concentrates Market Analysis

Saudi Arabia Bone Marrow Aspirate Concentrates Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of musculoskeletal disorders, growing awareness and acceptance of regenerative medicine, advancements in cell-based therapies, a favourable regulatory environment, and ongoing research and clinical trials exploring new applications are driving the bone marrow aspirate concentrates market. The bone marrow aspirate concentrates market is dominated by a few prominent players. Cesca Therapeutics Inc., Terumo BCT, Inc., Zimmer Biomet Holdings, Inc., and Regenexx are among the companies actively involved in the development, production, and commercialization of bone marrow aspirate concentrate products.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Burn Care Market Analysis

Saudi Arabia Burn Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of burns, driven by factors such as fire accidents, industrialization, and lifestyle changes. Additionally, Technological advancements in burn care products, including advanced dressings and wound care solutions, improving treatment outcomes have been the driving force for the market. Growing awareness, education, and healthcare expenditure, leading to increased demand for burn care services and products. Some of the global key players in the burn care market include Johnson & Johnson, 3M Company, Smith & Nephew, Mölnlycke Health Care, ConvaTec Group, Coloplast, and Derma Sciences.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Burn Ointment Market Analysis

Saudi Arabia Burn Ointment Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The burn ointment market is driven by factors such as the increasing incidence of burns, growing awareness about burn care, advancements in burn treatment technologies, rising healthcare expenditure, the aging population, and product innovations and market competition. Johnson & Johnson, Smith & Nephew plc, ConvaTec Group PLC, Medline Industries, B. Braun Melsungen AG, Derma Sciences, 3M Company, Acelity L.P. Inc., Hollister Incorporated, Molnlycke Health Care AB are among the global market leaders in Burn Ointment Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cancer Supportive Care Drugs Market Analysis

Saudi Arabia Cancer Supportive Care Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030.Cancer incidence, enhanced medicines, patient-centric care, awareness, government backing, technology improvements, and an ageing population are driving the cancer supportive care medications industry. Amgen, Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc., Heron Therapeutics, Inc., Novartis AG, GSK plc, F. Hoffmann-La Roche Ltd., and Helsinn Healthcare SA are among the global market leaders in cancer supportive care medications.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cannabidiol (CBD) Market Analysis

Saudi Arabia Cannabidiol (CBD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing consumer demand for CBD products due to increased awareness of their potential health benefits, legalisation efforts in many regions, expanding product applications, increasing awareness and education, shifting consumer preferences toward natural alternatives, favourable regulatory environment, and growing investment and industry support are the drivers for the cannabidiol (CBD) market. CV Sciences, Elixinol LLC, Medterra, NuLeaf Naturals, and Charlotte's Web are global leaders in the Cannabidiol (CBD) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cannabis Market Analysis

Saudi Arabia Cannabis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the cannabis industry include the increasing trend of legalization, both for medical and recreational purposes, which expands the market and drives demand. The growing acceptance of cannabis for medical applications, as it provides relief for various conditions, contributes to market growth. In the global cannabis market, several prominent players have established their presence. Companies such as Canopy Growth Corporation, Curaleaf Holdings, Inc., Green Thumb Industries Inc. (GTI), etc., have gained significant market share.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Carboprost Tromethamine Market Analysis

Saudi Arabia Carboprost Tromethamine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of postpartum haemorrhage, increased focus on maternal healthcare, developments in healthcare infrastructure, technological innovations in drug delivery, increasing maternal age, and supportive government initiatives are driving the carboprost tromethamine market. Pfizer Inc., Ferring Pharmaceuticals, JHP Pharmaceuticals, Hikma Pharmaceuticals, and Hemofarm A.D. are some of the leading global key competitors in the carboprost tromethamine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cartilage Repair/Regeneration Market Analysis

Saudi Arabia Cartilage Repair/Regeneration Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The global cartilage repair market is expanding rapidly because to an ageing population, rising obesity, rising healthcare spending, and an increase in sports-related injuries. Furthermore, a surge in innovative product introductions and the growth of medical tourism, which is raising awareness about cartilage treatment modalities around the world, is fueling market growth. Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Arthrex, Stryker Corporation, Medtronic plc, Vericel Corporation, CONMED Corporation, Anika Therapeutics, Osiris Therapeutics, Misonix, BioTissue Technologies GmbH, Histogenics Corporation, RTI Surgical Holdings, Collagen Solutions Plc, Orthocell Limited are some of the global key players in Cartilage Repair/Regeneration Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cell Based Immunotherapy Market Analysis

Saudi Arabia Cell Based Immunotherapy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of cancer, advancements in cell therapy technologies, a favourable regulatory environment, growing investments and collaborations, the trend toward personalised medicine, positive clinical outcomes, and patient demand for effective and targeted treatments are driving the cell-based immunotherapy market. Novartis, Gilead Sciences, Bristol Myers Squibb, bluebird bio, Adaptimmune Therapeutics, Cellectis, and Precision Biosciences are among the leading global players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cholesterol / Lipid Lowering Drugs Market Analysis

Saudi Arabia Cholesterol / Lipid Lowering Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising global prevalence of cardiovascular diseases, increased awareness about the health risks associated with high cholesterol levels, the ageing population, sedentary lifestyles, unhealthy dietary habits, and the need for effective treatments are some of the key drivers in the cholesterol/lipid lowering drugs market. growth. Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, and Dr. Reddy’s Laboratories Ltd.are global key players in Cholesterol / Lipid Lowering Drugs Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Chondroitin Market Analysis

Saudi Arabia Chondroitin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for chondroitin is driven by factors such as the increasing prevalence of musculoskeletal disorders and osteoarthritis, the growing aging population, rising consumer awareness about the benefits of natural and alternative therapies, and the demand for effective and safe solutions for joint health. Synutra Pure Ltd., TSI Group Ltd. Bioiberica S.A.U., Seikagaku Corporation, etc. are some of the global companies in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Coenzyme Q10 Market Analysis

Saudi Arabia Coenzyme Q10 Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Coenzyme Q10 market can witness growth due to factors such as increased consumer awareness, rising demand for dietary supplements and functional foods, growing interest in anti-aging and cardiovascular health applications in healthcare, the aging population, rising health consciousness, and product innovation. Prominent global players in the Coenzyme Q10 (CoQ10) market include Kaneka Corporation, DSM Nutritional Products, Hwail Pharmaceutical Co., Ltd., Tishcon Corporation, and Healthy Origins.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cold Plasma Market Analysis

Saudi Arabia Cold Plasma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased demand in healthcare and medical applications, increased requirement for food safety and sterilisation, environmental sustainability, and developments in the electronics and semiconductor industries are driving the cold plasma industry. Tantec A/S, Enercon Industries, Henniker Plasma, Nordson Corporation, Apex Medical Corporation, Adtec Plasma Technology Co. Ltd, P2i, Relyon Plasma GmbH, AcXys Plasma Technologies, and Plasmatreat are some of the global competitors in the cold plasma industry.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up